Holen Sie sich die Stockscreener-App
0.00
100.00%
-6.27
Handel nachbörslich:
6.01
6.01
+
Schlusskurs vom Vortag:
$6.27
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$9.28M
Einnahmen:
$15.81M
Nettoeinkommen (Verlust:
$-4.90M
KGV:
0.00
EPS:
-3.42
Netto-Cashflow:
$-2.65M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$6.77
52-Wochen-Spanne:
$0.00
$10.74
Precipio Inc Stock (PRPO) Company Profile
Firmenname
Precipio Inc
Sektor
Branche
Telefon
203 787 7888
Adresse
12325 EMMET ST, OMAHA, CT
Vergleichen Sie PRPO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
0.00 | 9.28M | 15.81M | -4.90M | -2.65M | -3.42 |
|
TMO
Thermo Fisher Scientific Inc
|
497.60 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.00 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
419.95 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.98 | 33.45B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
176.30 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Precipio Inc Aktie (PRPO) Neueste Nachrichten
Earnings call transcript: Precipio Q4 2024 sees revenue growth, strategic shifts - Investing.com India
Precipio Full Year 2024 Earnings: US$2.93 loss per share (vs US$4.51 loss in FY 2023) - Yahoo Finance
Precipio announces executive option grants tied to stock performance - MSN
Precipio Announces Q4 and year-end 2024 Shareholder Update Call - The Manila Times
Precipio, Inc. to Host Q4 and Year-End 2024 Corporate Update Call on March 31, 2025 - Nasdaq
Precipio to Reveal Full Year Performance: Key Updates Coming March 31 - StockTitan
(PRPO) Trading Advice - Stock Traders Daily
Precipio (NASDAQ:PRPO) Stock Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Precipio, Inc. to Host Earnings Call - ACCESS Newswire
Objective long/short (PRPO) Report - news.stocktradersdaily.com
Precipio (NASDAQ:PRPO) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Precipio Re-Launches All CLIA Lab and Pharmacological Research Projects at its New Haven, CT Facility - ACCESS Newswire
Precipio, Inc. Announces Pricing Of $2,748,000 Registered Direct Offering - ACCESS Newswire
Precipio achieves positive adjusted EBITDA, cash flow in Q4 - Yahoo Finance
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) - TradingView
Precipio, Inc. Reports Positive Adjusted EBITDA and Cash Flow for Q4 2024 - Nasdaq
How Precipio Finally Turned the Corner: Inside the Q4 Financial Breakthrough - StockTitan
(PRPO) Trading Report - Stock Traders Daily
Investors Still Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues Despite 28% Price Jump - Simply Wall St
Precipio Announces Q3-2019 Corporate Update Call for Shareholders - ACCESS Newswire
PRPO stock touches 52-week high at $7.42 amid market optimism - MSN
Precipio (NASDAQ:PRPO) Stock Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - br.ADVFN.com
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results - br.ADVFN.com
PRPOPrecipio Granted 180 Day NASDAQ Extension to Regain Compliance - br.ADVFN.com
(PRPO) Proactive Strategies - Stock Traders Daily
Precipio (NASDAQ:PRPO) Stock Passes Above 200 Day Moving Average – Here’s Why - Armenian Reporter
Precipio Grants Options to Officers as Part of Long-Term Incentive Equity Program - Defense World
Precipio announces executive option grants tied to stock performance By Investing.com - Investing.com UK
Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs - The Manila Times
Precipio Adopts Performance-Based Stock Options for 2025 - TipRanks
Precipio Management Bets Big: Opts for Stock Options That Only Vest at $30 Share Price - StockTitan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio - Yahoo Finance
Top Research Reports for Visa, AbbVie & Analog Devices - Yahoo Finance
Investors Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues - Simply Wall St
Long Term Trading Analysis for (PRPO) - Stock Traders Daily
Precipio (NASDAQ:PRPO) Stock Quotes, Forecast and News Summary - Benzinga
(PRPO) Trading Signals - Stock Traders Daily
PRPO (Precipio) 3-Year Book Growth Rate : -14.20% (As of Sep. 2024) - GuruFocus.com
How to Take Advantage of moves in (PRPO) - Stock Traders Daily
PRPO (Precipio) 3-Year EPS without NRI Growth Rate : 28.00% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) 3-Year EBITDA Growth Rate : 32.10% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) 3-Year Revenue Growth Rate : 16.60% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) Future 3-5Y Total Revenue Growth Rate : N/A (As of Nov. 26, 2024) - GuruFocus.com
PRPO (Precipio) Growth Rank : 3 (As of Nov. 25, 2024) - GuruFocus.com
Two Smaller Companies Worthy of Your "Attention" - Yahoo Finance
PRPO (Precipio) 3-Year FCF Growth Rate : 32.40% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) GF Value Rank : 2 (As of Nov. 23, 2024) - GuruFocus.com
PRPO (Precipio) Debt-to-Equity : 0.11 (As of Sep. 2024) - GuruFocus.com
Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ... - Yahoo Finance
Finanzdaten der Precipio Inc-Aktie (PRPO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):